These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 24176499)

  • 21. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
    Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
    Front Immunol; 2022; 13():838504. PubMed ID: 35211125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.
    Hendrikx LH; Felderhof MK; Oztürk K; de Rond LG; van Houten MA; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Dec; 30(1):51-8. PubMed ID: 22064265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.
    Esposito S; Agliardi T; Giammanco A; Faldella G; Cascio A; Bosis S; Friscia O; Clerici M; Principi N
    Infect Immun; 2001 Jul; 69(7):4516-20. PubMed ID: 11401994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.
    Hendrikx LH; Öztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM
    PLoS One; 2011; 6(11):e27681. PubMed ID: 22110718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
    Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
    Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific immune response in adult medical personnel immunized with acellular pertussis vaccine with special emphasis on T helper cell response.
    Lin TY; Chiang BL
    Vaccine; 1997 Dec; 15(17-18):1917-21. PubMed ID: 9413102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.
    da Silva Antunes R; Babor M; Carpenter C; Khalil N; Cortese M; Mentzer AJ; Seumois G; Petro CD; Purcell LA; Vijayanand P; Crotty S; Pulendran B; Peters B; Sette A
    J Clin Invest; 2018 Aug; 128(9):3853-3865. PubMed ID: 29920186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a
    da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A
    J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin Clears
    Borkner L; Misiak A; Wilk MM; Mills KHG
    Front Immunol; 2018; 9():1764. PubMed ID: 30105030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
    Ryan M; Gothefors L; Storsaeter J; Mills KH
    Dev Biol Stand; 1997; 89():297-305. PubMed ID: 9272363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to pertussis vaccines and disease.
    Edwards KM; Berbers GA
    J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.
    Bancroft T; Dillon MB; da Silva Antunes R; Paul S; Peters B; Crotty S; Lindestam Arlehamn CS; Sette A
    Cell Immunol; 2016; 304-305():35-43. PubMed ID: 27212461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.
    Rieber N; Graf A; Belohradsky BH; Hartl D; Urschel S; Riffelmann M; Wirsing von König CH; Liese J
    Vaccine; 2008 Dec; 26(52):6929-35. PubMed ID: 18852002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.
    Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
    Clin Vaccine Immunol; 2012 Nov; 19(11):1879-86. PubMed ID: 23015649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
    Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
    Fadugba OO; Wang L; Chen Q; Halasa NB
    Clin Vaccine Immunol; 2014 Dec; 21(12):1613-9. PubMed ID: 25253666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.